| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $468,720 | 4 | 44 |
Sells | $9,634,240 | 5 | 56 |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER | 1 | $302,000 | 0 | $0 | $302,000 |
| BOLL ANDREW R. | PRESIDENT AND CFO | 1 | $104,650 | 0 | $0 | $104,650 |
| Graves Adrienne L | director | 1 | $31,070 | 0 | $0 | $31,070 |
| SILVERNAIL LAUREN P | director | 1 | $31,000 | 0 | $0 | $31,000 |
| Shojaei Amir | CHIEF SCIENTIFIC OFFICER | 0 | $0 | 1 | $450,000 | $-450,000 |
| Opaleye Management Inc. | 10 percent owner | 0 | $0 | 4 | $9.18M | $-9.18M |
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures. These encompass Surface Ophthalmics, Inc., a clinical-stage firm actively developing and commercializing therapeutic agents for …
Over the last 12 months, insiders at Harrow Health, Inc. have bought $468,720 and sold $9.63M worth of Harrow Health, Inc. stock.
On average, over the past 5 years, insiders at Harrow Health, Inc. have bought $2.17M and sold $4.3M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BAUM MARK L (CHIEF EXECUTIVE OFFICER) — $302,000. BOLL ANDREW R. (PRESIDENT AND CFO) — $104,650. Graves Adrienne L (director) — $31,070.
The last purchase of 1,000 shares for transaction amount of $31,000 was made by SILVERNAIL LAUREN P (director) on 2026‑05‑18.
| 2026-08-14 | Sale | Shojaei Amir | CHIEF SCIENTIFIC OFFICER | 11,250 0.0301% | $40.00 | $450,000 | -17.37% | |
| 2026-05-18 | SILVERNAIL LAUREN P | director | 1,000 0.0027% | $31.00 | $31,000 | +21.23% | ||
| 2026-05-18 | Graves Adrienne L | director | 1,000 0.0027% | $31.07 | $31,070 | +21.23% | ||
| 2026-05-14 | BAUM MARK L | CHIEF EXECUTIVE OFFICER | 10,000 0.0263% | $30.20 | $302,000 | +20.77% | ||
| 2026-05-14 | BOLL ANDREW R. | PRESIDENT AND CFO | 3,500 0.0091% | $29.90 | $104,650 | +20.77% | ||
| 2026-03-04 | Sale | Opaleye Management Inc. | 10 percent owner | 138,263 0.3776% | $39.67 | $5.49M | -5.89% | |
| 2026-03-03 | Sale | Opaleye Management Inc. | 10 percent owner | 60,309 0.119% | $39.15 | $2.36M | -4.34% | |
| 2026-02-27 | Sale | Opaleye Management Inc. | 10 percent owner | 5,000 0.0135% | $54.18 | $270,900 | -31.79% | |
| 2026-01-06 | Sale | Opaleye Management Inc. | 10 percent owner | 20,000 0.0526% | $53.35 | $1.07M | -27.78% | |
| 2025-06-10 | Sale | Opaleye Management Inc. | 10 percent owner | 15,000 0.0404% | $30.80 | $462,033 | +24.38% | |
| 2025-06-09 | Sale | Opaleye Management Inc. | 10 percent owner | 15,204 0.0417% | $30.37 | $461,794 | +28.59% | |
| 2025-06-04 | Sale | Opaleye Management Inc. | 10 percent owner | 1,796 0.005% | $30.02 | $53,907 | +31.38% | |
| 2025-06-03 | Sale | Opaleye Management Inc. | 10 percent owner | 3,000 0.0084% | $30.04 | $90,116 | +32.14% | |
| 2025-05-13 | Sale | Opaleye Management Inc. | 10 percent owner | 5,000 0.0138% | $26.59 | $132,945 | +47.58% | |
| 2025-05-12 | Sale | Opaleye Management Inc. | 10 percent owner | 10,000 0.0265% | $25.90 | $258,959 | +45.42% | |
| 2025-03-24 | Sale | Opaleye Management Inc. | 10 percent owner | 5,000 0.014% | $30.01 | $150,055 | +25.53% | |
| 2025-03-18 | Sale | Opaleye Management Inc. | 10 percent owner | 5,000 0.0154% | $29.64 | $148,200 | +39.58% | |
| 2025-03-18 | Sale | Opaleye Management Inc. | 10 percent owner | 5,000 0.0156% | $30.01 | $150,055 | +39.58% | |
| 2025-02-28 | Sale | Opaleye Management Inc. | 10 percent owner | 5,000 0.0142% | $28.05 | $140,250 | +33.26% | |
| 2025-01-22 | Sale | Opaleye Management Inc. | 10 percent owner | 20,000 0.0583% | $35.59 | $711,814 | -1.19% |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER | 2996130 7.9923% | $85.51M | 6 | 0 | +62.47% |
| BOLL ANDREW R. | PRESIDENT AND CFO | 814679 2.1732% | $23.25M | 3 | 0 | +35.66% |
| Opaleye Management Inc. | 10 percent owner | 59428 0.1585% | $1.7M | 29 | 15 | +61.71% |
| SILVERNAIL LAUREN P | director | 1000 0.0027% | $28,540.00 | 1 | 0 | |
| Graves Adrienne L | director | 1000 0.0027% | $28,540.00 | 1 | 0 | |
| Singh Juliet | CEO, Director and President | 1954125 5.2127% | $55.77M | 2 | 0 | |
| THORNLEY ANTHONY S | director | 60900 0.1625% | $1.74M | 6 | 0 | |
| Makary Martin A. | director | 45000 0.12% | $1.28M | 2 | 0 | +1.45% |
| LINDSTROM RICHARD L MD | 26100 0.0696% | $744,894.00 | 1 | 1 | +43.9% | |
| Van Horn R. Lawrence | director | 1860 0.005% | $53,084.40 | 1 | 0 | +27.43% |
$1,279,728,023 | 131 | 10.76% | $3.05B | |
$14,599,168 | 59 | 12.79% | $1.66B | |
$102,709,455 | 46 | 30.55% | $1.45B | |
$73,762,556 | 45 | -9.99% | $2.17B | |
$98,035,963 | 43 | -10.97% | $486.79M |
| Increased Positions | 113 | +50.45% | 3M | +13.51% |
| Decreased Positions | 96 | -42.86% | 2M | -8.05% |
| New Positions | 47 | New | 1M | New |
| Sold Out Positions | 29 | Sold Out | 771,791 | Sold Out |
| Total Postitions | 241 | +7.59% | 22M | +5.46% |
| Opaleye Management Inc. | $194,899.00 | 10.55% | 3.9M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $127,321.00 | 6.9% | 2.55M | -14,579 | -0.57% | 2025-09-30 |
| Vanguard Group Inc | $93,371.00 | 5.06% | 1.87M | +1,534 | +0.08% | 2025-09-30 |
| Private Capital Management, Llc | $92,616.00 | 5.01% | 1.86M | -89,697 | -4.61% | 2025-09-30 |
| State Street Corp | $39,643.00 | 2.15% | 794,282 | +21,177 | +2.74% | 2025-09-30 |
| Geode Capital Management, Llc | $38,712.00 | 2.1% | 775,644 | -35,159 | -4.34% | 2025-09-30 |
| Royce & Associates Lp | $26,603.00 | 1.44% | 533,013 | -20,680 | -3.73% | 2025-09-30 |
| Marshall Wace, Llp | $25,360.00 | 1.37% | 508,116 | -56,760 | -10.05% | 2025-09-30 |
| Susquehanna International Group, Llp | $22,407.00 | 1.21% | 448,947 | +235,038 | +109.88% | 2025-09-30 |
| Braidwell Lp | $17,089.00 | 0.93% | 342,391 | -529,855 | -60.75% | 2025-09-30 |